How Hims & Hers Reached a $4.3BN Market Cap on $2.3BN of Revenue

Andrew Dudum is the Founder and CEO of Hims, the company reshaping consumers relationship to healthcare. It has been a rocky ride over the last 6 months, the company is down 66%, their market cap today is $4.3BN on $2.3BN of revenue. They just bought their largest international competitor, Eucalyptus for $1.5BN.

———————————————–

Timestamps:
00:00 Intro
01:17 Why Running a Public Company Is More Fun Than Being Private
05:07 How to Hire for Grit: People Who Have Been Through Shit
08:31 Founder Mode vs Trusting Your Team
10:58 How Many Employees Will Hims Have in 2030?
11:08 Where AI Is Having the Biggest Impact at Hims
13:58 Hims Is Not a Weight Loss Business
14:45 Running Hims Like a Venture Portfolio of Bets
16:51 First to Market vs. Best in Market
19:02 Why Hims Wants to Be Both Price King and Feature King
21:06 How Hims Helped Cut GLP-1 Prices by 80% in 18 Months
25:27 Is ChatGPT the Biggest Threat or the Biggest Opportunity?
28:26 How AI Overviews Are Changing Patient Acquisition
29:58 The Eucalyptus Acquisition & Going Global
32:56 The Fine Line Between Aggressive Growth and Losing Control
36:56 What Andrew Got Wrong About Brand Marketing
39:00 Why Great Brands Say the Same Thing in 20 Different Ways
43:22 The Vision: Free Preventative Health as a Loss Leader
44:33 The At-Home Blood Testing Device That Could Change Everything
46:57 Why Not Every Product Line Has to Be Profitable
48:12 Why the US Healthcare System’s Incentives Are Totally Broken
52:05 Why Hims Gets Dunked on More Than Competitors
53:49 The Part of the Healthcare System Hims Most Wants to Break
59:15 Quick-Fire Round